2011 - IPITA - Prague


Parallel session 3 – Open oral presentations Topic: Stem cells

3.6 - Insulin-producing cells derived from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice

Presenter: M., Ghoneim, Mansoura, Egypt
Authors: M. Gabr, M. Zakaria, A. Refaie, A. Mostafa, M. Abou-El-Mahasen, S. Ashamallah, S. Khater, S. El-Halawani, R. Ibrahim, G. Shu Uin, M. Kloc, A. Clark, R. Calne, M. Ghoneim



Insulin-producing cells derived from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice

M. Gabr1, M. Zakaria1, A. Refaie1, A. Mostafa1, M. Abou-El-Mahasen1, S. Ashamallah1, S. Khater1, S. El-Halawani1, R. Ibrahim1, G. Shu Uin2, M. Kloc3, A. Clark4, R. Calne5, M. Ghoneim1
1 Urology & Nephrology Center, Mansoura, Egypt; 2 Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 3 The Methodist Hospital Research Institute,, Houston, Texas, USA; 4 Oxford Center for Diabetes, Endocrinology and Metabolism, Oxford, U.K.; 5 Cambridge University, Cambridge, U.K.

Background: Harvesting, expansion and directed differentiation of human bone marrow-derived mesenchymal stem cells (MSCs) would provide an autologous source of surrogate β-cells that alleviate the limitations of availability and/or allogenic rejection following pancreatic or islet transplantation.

Methods: Bone marrow cells were obtained from three adult type II diabetic volunteers and 3 non-diabetic donors. After 3 days in culture; adherent MSCs were expanded for 2 passages. At passage 3, differentiation was carried out in a 3-staged procedure. Cells were cultured in a glucose-rich medium containing several activation and growth factors. These cells were evaluated in-vitro by immunofluoresce,electron microscopy and Rt-PCR. Insulin and c-peptide release in response to increasing glucose concentrations was determined.

Results: By immunofluorescence, some cells tested positively for insulin, c-peptide and glucagon with co-expression of insulin and c-peptide by the same cells. Nanogold immunostaining for electron microscopy demonstrated the presence of c-peptide at the rough endoplasmic reticulum. These insulin-producing cells (IPCs), expressed a variety of transcription factors and genes of pancreatic hormones closely similar to those of pancreatic islets. There was a stepwise increase in insulin and c-peptide release by these cells in response to increasing glucose concentrations. One thousand clusters inserted under the renal capsule of diabetic nude mice resulted in control of their diabetic status for 3 months. The sera of treated mice contained human insulin, human c-peptide but negligible levels of mouse insulin. When the IPCs-bearing kidneys were removed, rapid return of diabetic state was noted. Histology of the removed kidneys showed insulin staining cells under the capsule.

Conclusion: MSCs could be differentiated to form IPCs. The implanted IPCs could control diabetic nude mice and maintain their euglycaemic state for 3 months. Optimization of the culture conditions and/or the differentiation techniques are needed to improve the functional performance of these cells.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi